|Bid||53.87 x 1800|
|Ask||53.98 x 4000|
|Day's Range||51.13 - 52.70|
|52 Week Range||38.48 - 61.71|
|Beta (5Y Monthly)||0.72|
|PE Ratio (TTM)||15.40|
|Earnings Date||May 02, 2022 - May 06, 2022|
|Forward Dividend & Yield||1.60 (3.21%)|
|Ex-Dividend Date||May 12, 2022|
|1y Target Est||59.33|
In this article, we discuss the top 10 value stocks hedge funds are buying in 2022. If you want to see more of the value stocks that elite investors are favoring, click Top 5 Value Stocks Hedge Funds are Buying in 2022. As the Federal Reserve signals further monetary tightening, hedge funds and retail investors […]
Pfizer (PFE) obtains Fast Track designation for its investigational combination therapy - ervogastat and clesacostat for the treatment of NASH.
European Commission authorizes a booster dose of AstraZeneca's (AZN) COVID-19 vaccine and approves Merck (MRK) and Roche's (RHHBY) oncology drugs for expanded use.